Rhein affects arylamine N-acetyltransferase activity in Helicobacter pylori from peptic ulcer patients.

Article Details

Citation

Chung JG, Tsou MF, Wang HH, Lo HH, Hsieh SE, Yen YS, Wu LT, Chang SH, Ho CC, Hung CF

Rhein affects arylamine N-acetyltransferase activity in Helicobacter pylori from peptic ulcer patients.

J Appl Toxicol. 1998 Mar-Apr;18(2):117-23.

PubMed ID
9570694 [ View in PubMed
]
Abstract

Arylamine N-acetyltransferase (NAT) activities with 2-aminofluorene and p-aminobenzoic acid were determined in the bacterium Helicobacter pylori collected from peptic ulcer patients. Cytosols or suspensions of H. pylori with or without specific concentrations of rhein co-treatment showed different percentages of 2-aminofluorene and p-aminobenzoic acid acetylation. The data indicate that there was decreased NAT activity associated with increased levels of rhein in H. pylori cytosols. Inhibition of growth studies from H. pylori demonstrated that rhein elicited dose-dependent bacteriostatic activity in H. pylori cultures: i.e. the greater the concentration of rhein, the greater the inhibition of growth to H. pylori. For the cytosol and intact bacteria examination, the apparent values of Km and Vmax were decreased after co-treatment with 40 microM rhein. This report is the first demonstration of rhein inhibition of arylamine N-acetyltransferase activity and rhein inhibition of growth in the bacterium H. pylori.

DrugBank Data that Cites this Article

Drugs
Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
DiacereinArylamine N-acetyltransferaseGroupHelicobacter pylori
Unknown
Inhibitor
Details
RheinArylamine N-acetyltransferaseGroupHelicobacter pylori
Unknown
Inhibitor
Details